PROX1 and glioma: Glioma, esophageal carcinoma and colon cancer display high PROX1 levels10–13 indicative of an oncogenic role, while in hepatocellular carcinoma (HCC) PROX1 expression is reduced, suggesting a tumour-suppressive role14–16.